标题
Regulation of PD-L1 Expression by NF-κB in Cancer
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-11-25
DOI
10.3389/fimmu.2020.584626
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28
- (2020) F.R. Mariotti et al. BRITISH JOURNAL OF PHARMACOLOGY
- Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC
- (2020) Chiara Porta et al. CANCER RESEARCH
- PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
- (2020) Brian Diskin et al. NATURE IMMUNOLOGY
- Hyperprogression Under Immune Checkpoint-Based Immunotherapy—Current Understanding, The Role of PD-1/PD-L1 Tumour-Intrinsic Signalling, Future Directions and a Potential Large Animal Model
- (2020) Mikolaj Kocikowski et al. Cancers
- Corrigendum to “IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway” [Biomed. Pharmacother. 123 (2020) 109790]
- (2020) Hongning Cai et al. BIOMEDICINE & PHARMACOTHERAPY
- NF-κB and Its Role in Checkpoint Control
- (2020) Annika C. Betzler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Senescent cells: Living or dying is a matter of NK cells
- (2019) Fabrizio Antonangeli et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): What to add and what to leave out
- (2019) C. Proto et al. CANCER TREATMENT REVIEWS
- Hypoxia‐inducible factor‐1α and nuclear factor‐κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non‐small‐cell lung cancer cells
- (2019) Rong Guo et al. CANCER SCIENCE
- Upregulation of PD-L1 via HMGB1-activated IRF3 and NF-kB contributes to UV radiation-induced immune suppression
- (2019) Wei Wang et al. CANCER RESEARCH
- Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action
- (2019) Ni Zhang et al. Immunotherapy
- The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors
- (2019) Maria Pia Abruzzese et al. Cell Death & Disease
- Immune Checkpoint Ligand Reverse Signaling: Looking Back to Go Forward in Cancer Therapy
- (2019) Daniele Lecis et al. Cancers
- Melanoma extracellular vesicles generate immunosuppressive myeloid cells by PD-L1 upregulation via TLR4 signaling
- (2019) Viktor Fleming et al. CANCER RESEARCH
- The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
- (2019) Yuan Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
- (2019) Francesca Maria Consonni et al. Frontiers in Immunology
- Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions
- (2019) Francesca Romana Mariotti et al. Frontiers in Immunology
- Genome reading by the NF-κB transcription factors
- (2019) Maria Carmen Mulero et al. NUCLEIC ACIDS RESEARCH
- Interferon target-gene expression and epigenomic signatures in health and disease
- (2019) Franck J. Barrat et al. NATURE IMMUNOLOGY
- The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
- (2019) Weiting Qin et al. Frontiers in Immunology
- NLRP2 Regulates Proinflammatory and Antiapoptotic Responses in Proximal Tubular Epithelial Cells
- (2019) Marianna N. Rossi et al. Frontiers in Cell and Developmental Biology
- Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer
- (2019) Jianchun Duan et al. JAMA Oncology
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
- (2018) Frederick Arce Vargas et al. CANCER CELL
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling
- (2018) Yi Gao et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy
- (2018) Bo Zhu et al. ONCOGENE
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- NF-kappaB: Two Sides of the Same Coin
- (2018) Bruno Pires et al. Genes
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
- (2018) Rebekka Weber et al. Frontiers in Immunology
- PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma
- (2018) A. Asgarova et al. OncoImmunology
- Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling
- (2018) Justin Lucas et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- LPS promotes the expression of PD-L1 in gastric cancer cells through NF-κB activation
- (2018) Hui Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
- (2018) Jack Prescott et al. Cells
- Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
- (2018) Peixin Dong et al. Frontiers in Oncology
- The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma
- (2018) Dávid Vrábel et al. BLOOD REVIEWS
- Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression
- (2018) Xin Jin et al. MOLECULAR CELL
- Induction of immunosuppressive functions and NF-κB by FLIP in monocytes
- (2018) Alessandra Fiore et al. Nature Communications
- Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
- (2018) Andrew Paul et al. Cells
- Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade
- (2018) Giuseppe Lo Russo et al. CLINICAL CANCER RESEARCH
- Avelumab: combining immune checkpoint inhibition and antibody-dependent cytotoxicity
- (2017) Gerhard Hamilton et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma
- (2017) Kazuto Harada et al. Gastric Cancer
- Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
- (2017) Xun Wang et al. IMMUNOLOGY LETTERS
- PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
- (2017) Xiaohui Zhang et al. International Journal of Clinical Oncology
- Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
- (2017) Jinfang Zhang et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer
- (2017) A Bouillez et al. ONCOGENE
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
- (2017) Takuro Noguchi et al. Cancer Immunology Research
- How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
- (2017) Fabrizio Antonangeli et al. Frontiers in Immunology
- The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
- (2017) Muhammad Zaeem Noman et al. OncoImmunology
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- Dual Faces of IFN in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
- (2016) M. Mandai et al. CLINICAL CANCER RESEARCH
- Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
- (2016) Frank A. Schildberg et al. IMMUNITY
- PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
- (2016) Xi-wen Bi et al. Journal of Hematology & Oncology
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway
- (2016) Maroof Alam et al. MOLECULAR CANCER RESEARCH
- Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
- (2016) Michiel van der Vlist et al. Nature Reviews Rheumatology
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells
- (2016) Chunwan Lu et al. OncoImmunology
- Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways
- (2016) Ling-Ling An et al. Scientific Reports
- EGFR-TKI down-regulates PD-L1 in EGFR mutant NSCLC through inhibiting NF-κB
- (2015) Kailong Lin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- Metabolic Reprogramming of Immune Cells in Cancer Progression
- (2015) Subhra K. Biswas IMMUNITY
- MUC1-C activates the TAK1 inflammatory pathway in colon cancer
- (2015) H Takahashi et al. ONCOGENE
- Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma
- (2015) Patcharee Ritprajak et al. ORAL ONCOLOGY
- Temporal regulation of HIF-1 and NF-κB in hypoxic hepatocarcinoma cells
- (2015) Yuan Jiang et al. Oncotarget
- LDL suppresses angiogenesis through disruption of the HIF pathway via NF-κB inhibition which is reversed by the proteasome inhibitor BSc2118
- (2015) Gang Yao et al. Oncotarget
- ERβ regulation of NF-kB activation in prostate cancer is mediated by HIF-1
- (2015) Paul Mak et al. Oncotarget
- Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB
- (2015) Kavitha Gowrishankar et al. PLoS One
- IL-12 Regulates B7-H1 Expression in Ovarian Cancer-associated Macrophages by Effects on NF-κB Signalling
- (2014) Hai-Yu Xiong et al. Asian Pacific Journal of Cancer Prevention
- Tuning of Antigen Sensitivity by T Cell Receptor-Dependent Negative Feedback Controls T Cell Effector Function in Inflamed Tissues
- (2014) Tetsuya Honda et al. IMMUNITY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer
- (2014) Jinpu Yu et al. JOURNAL OF IMMUNOLOGY
- Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151
- (2014) Stuart J. Gallagher et al. Pigment Cell & Melanoma Research
- PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells
- (2014) Hatem Soliman et al. PLoS One
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial–mesenchymal transition
- (2013) H Rajabi et al. ONCOGENE
- NF-κB Plays a Key Role in Inducing CD274 Expression in Human Monocytes after Lipopolysaccharide Treatment
- (2013) Gang Huang et al. PLoS One
- CD40-Mediated Activation of the NF-κB2 Pathway
- (2013) Bruce S. Hostager et al. Frontiers in Immunology
- NF-κB and the link between inflammation and cancer
- (2012) Joseph A. DiDonato et al. IMMUNOLOGICAL REVIEWS
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Reflections on the Field of Photoimmunology
- (2012) Margaret L. Kripke JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
- (2012) D W Kufe ONCOGENE
- Immunoregulatory Molecule B7-H1 (CD274) Contributes to Skin Carcinogenesis
- (2011) Y. Cao et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- NF-κB in immunobiology
- (2011) Matthew S Hayden et al. CELL RESEARCH
- Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines
- (2011) Yongjing Chen et al. CYTOKINE
- Anergic CD8+ T Lymphocytes Have Impaired NF- B Activation with Defects in p65 Phosphorylation and Acetylation
- (2011) P. E. Clavijo et al. JOURNAL OF IMMUNOLOGY
- Return to homeostasis: downregulation of NF-κB responses
- (2011) Jürgen Ruland NATURE IMMUNOLOGY
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth
- (2011) T J Standiford et al. ONCOGENE
- Extensive characterization of NF-κB binding uncovers non-canonical motifs and advances the interpretation of genetic functional traits
- (2011) Daniel Wong et al. GENOME BIOLOGY
- Interferon- and tumor necrosis factor- induce an immunoinhibitory molecule, B7-H1, via nuclear factor- B activation in blasts in myelodysplastic syndromes
- (2010) A. Kondo et al. BLOOD
- ATM- and NEMO-Dependent ELKS Ubiquitination Coordinates TAK1-Mediated IKK Activation in Response to Genotoxic Stress
- (2010) Zhao-Hui Wu et al. MOLECULAR CELL
- COP9-Associated CSN5 Regulates Exosomal Protein Deubiquitination and Sorting
- (2009) Yuelong Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion
- (2009) Yadi Wu et al. CANCER CELL
- MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor- B p65 Transcription Factor
- (2009) R. Ahmad et al. CANCER RESEARCH
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
- (2009) Jose Miguel López-Novoa et al. EMBO Molecular Medicine
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor B
- (2009) C. Porta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Roles of the NF- B Pathway in Lymphocyte Development and Function
- (2009) S. Gerondakis et al. Cold Spring Harbor Perspectives in Biology
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
- (2008) T. Azuma et al. BLOOD
- Rel/NF-κB family member RelA regulates NK1.1− to NK1.1+ transition as well as IL-15-induced expansion of NKT cells
- (2008) Sivakumar Vallabhapurapu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
- (2008) M. Marzec et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now